Analyst Price Target is $40.25
▲ +79.37% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Privia Health Group in the last 3 months. The average price target is $40.25, with a high forecast of $57.00 and a low forecast of $31.00. The average price target represents a 79.37% upside from the last price of $22.44.
Current Consensus is
The current consensus among 9 polled investment analysts is to buy stock in Privia Health Group.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.